
"Performance" HAOHAI BIOTEC's annual net profit is 251 million RMB, down 40.3%, with a final dividend of 0.60 RMB
HAOHAI BIOTEC (06826.HK) announced its performance for the fiscal year 2025, with revenue of 2.446 billion RMB, a year-on-year decrease of 8.7%. It recorded a net profit of 251 million RMB, a decline of 40.3%, with earnings per share of 1.08 RMB. The final dividend remains at 0.60 RMB

